We built the commercial leader's public record around the buying problem rather than the product, which shortened the path from first contact to pilot and doubled qualified enterprise conversations.
A capable commercial team, a strong product, and a pipeline that only moved when a warm introduction appeared. Outbound was consuming most of the effort and producing the least.
We made the CCO publicly useful on the one thing buyers actually struggle with: proving value inside a health system budget cycle. Every piece was written for the people who sign, not the people who demo.
First meetings began with the buyer already understanding the thesis, qualified enterprise conversations doubled, and the average time from first contact to pilot fell by more than a third.
Clinicians nodded politely and never replied. Nine months later, four health systems opened the conversation themselves.
The deck was strong. The problem was that nobody had heard the argument behind it until the meeting started.
The company had clinical credibility sitting in one person. Nobody outside the building could see it.